Article info
PDFWhat neurologists need to understand outside their own speciality
Ataxia telangiectasia: what the neurologist needs to know
- Correspondence to Anke E Hensiek, Clinical Neurosciences, Addenbrookes Hospital, Cambridge CB2 2QQ, UK; Ahensiek{at}nhs.net
Citation
Ataxia telangiectasia: what the neurologist needs to know
Publication history
- Accepted April 8, 2020
- First published September 21, 2020.
Online issue publication
January 09, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- DNA repair disorders
- Autosomal recessive cerebellar ataxias: the current state of affairs
- Genotype–phenotype correlations in ataxia telangiectasia patients with ATM c.3576G>A and c.8147T>C mutations
- Ataxia in a young patient
- Ataxia telangiectasia: learning from previous mistakes
- Ataxia telangiectasia: presentation and diagnostic delay
- POG02 Variant ataxia telangiectasia in siblings with normal α-fetoprotein levels
- Expression of ATM, p53, and the MRE11–Rad50–NBS1 complex in myoepithelial cells from benign and malignant proliferations of the breast
- Integration of computer-aided automated analysis algorithms in the development and validation of immunohistochemistry biomarkers in ovarian cancer
- ATM germline variants and male breast cancer